Harpoon Therapeutics Inc.

NASDAQ: HARP · Real-Time Price · USD
23.01
0.02 (0.09%)
At close: Mar 08, 2024, 10:00 PM

Harpoon Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
51.61M 44.69M
Short-Term Investments
1.5M 90.41M
Long-Term Investments
673K 1.52M
Other Long-Term Assets
238K 860K
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
1.61M 2.6M
Total Current Assets
54.73M 137.69M
Property-Plant & Equipment
18.09M 15.38M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
19M 17.76M
Total Assets
73.73M 155.45M
Account Payables
4.71M 2.67M
Deferred Revenue
30.94M 37.46M
Short-Term Debt
2.42M 1.65M
Other Current Liabilities
14.36M 17.36M
Total Current Liabilities
52.43M 59.14M
Long-Term Debt
13.58M 10.54M
Other Long-Term Liabilities
n/a n/a
Total Long-Term Liabilities
15.9M 38.24M
Total Liabilities
68.33M 97.38M
Total Debt
16.01M 12.19M
Common Stock
4K 4K
Retained Earnings
-352.52M -284.79M
Comprehensive Income
-3K -47K
Shareholders Equity
5.4M 58.07M
Total Investments
1.5M 91.93M